aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 408,200 shares, an increase of 69.4% from the March 15th total of 240,900 shares. Based on an average daily volume of 302,800 shares, the days-to-cover ratio is […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) had its price target hoisted by Piper Sandler from $9.00 to $13.00 in a research report sent to investors on Tuesday, The Fly reports. The firm currently has an overweight rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. […]
aTyr Pharma (NASDAQ:LIFE – Get Rating) had its price objective increased by Piper Sandler from $9.00 to $13.00 in a report released on Tuesday, The Fly reports. They currently have an overweight rating on the biotechnology company’s stock. A number of other analysts have also recently commented on the stock. Royal Bank of Canada reiterated […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) has been given an average recommendation of “Moderate Buy” by the six brokerages that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among […]